{"name":"Alloplex Biotherapeutics Inc","slug":"alloplex-biotherapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNT1k0OU1wYnloemdmc1ZuQ0FGNlM5YzF2Smd4enRWYzBpX0dZWVdiRmtPdWhhTS00VkVqdzFMT1l0NVp3N2p2RWVySXF6QzM1VTR2OU9naWV5eGZXcjNDallQVUlJLXR6aHlKOG94c3BBMkxoVzdGLTdOSllBTFNjSm5GU1duUmstYkJYNGN6dktPSzA4Y2tYdnZuOURudHZ4bzdXNQ?oc=5","date":"2024-10-31","type":"trial","source":"Clinical Trials Arena","summary":"Alloplex’s cancer immunotherapy shows promise in Phase I trial - Clinical Trials Arena","headline":"Alloplex’s cancer immunotherapy shows promise in Phase I trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5pS0x3ZV81ZjhCc3BXS0pTbE13czNoR25VUzc1RVZxbHB1RXlkcFhYbl8wYmpVelNIOVh1NVBhd3VnT0xEaXhTRnFtaGt3VXhhNnZyaWNQa2FhTUdEbXRyUGd6a0p5M2JGS05zQg?oc=5","date":"2024-02-29","type":"regulatory","source":"Haematologica","summary":"Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post-hoc analysis of a large clinical trial safety d","headline":"Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patient","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxQTFp6LTlmYUJPMXpzTHJfbHlRYVpFdXk5ZmVjTE5OSmxYNUZFaE93ZWpwcHVzUXZTenBacTNvaVVfTGVKcXBCN3RsUllSZ04ydkFLZU82eGJtQ29BS2pHSlhpZmtMSzFxY0l4TjU5YzlhcTFaVGZROGdRRFRRZTA5WmY0dEprN3dncjdISTFKcjZQWlZtOFRlWldUeXBWUGE1SXhXY25JRklzVDMtOHkwMjAwZHplVldsckhsN0VRRXQ2UWtXTjgyVUNvMk5ad2VEMGNJWFV2RnVEYTh3cHJYUFI2VVNPVEhIUE5VV0psNVVmZXI4QlZXTFVSRzc1TDY2?oc=5","date":"2021-12-15","type":"pipeline","source":"prnewswire.com","summary":"Hackensack Meridian Health's Bear's Den Supports Company Developing Novel Way to 'Train' Patients' Own White Blood Cells - prnewswire.com","headline":"Hackensack Meridian Health's Bear's Den Supports Company Developing Novel Way to 'Train' Patients' Own White Blood Cells","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPRWZmQzBLejBGSDBIbGhiRDRRdElxeG1WRWFXdUI5YVhfOU5uakdUNmd1UWJZWnlPTTBnS2Y0dDc3X1RnRDRBVW1aakl2Q3RwejEycklnTXhlU0oxVlRBX0VnMnlxQkxIb2YxNTZsdUFoUGlPTjFUeDRkNXE0Ry1SSWlTVy1KZDJMTjNCNzJSQ0RQUUQ3cnFuaTVsYllwQ08wbkN1dXVXSm1uMjZVUU4zQg?oc=5","date":"2021-08-19","type":"pipeline","source":"BioSpace","summary":"Daewoong Pharmaceutical and Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics - BioSpace","headline":"Daewoong Pharmaceutical and Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxQVEd5Zmp5U1FsaGhFU2VRZ0ItS0E1VWpXei04TkpkM2N4TXdlUldvdUdWV0hlZHF1X3lxdjB5ME0zSG0wTmJyY2xsaFdzVTgycDB0ekwyZ0VnNHpwamNEVWY1c1dabTc1WW5zX3BfcXR5YnIxQmlNeG1kc1lhaTIwclJEdGJrVnd0VmJrckc5TWM0b3l2QXkxWDJqU3VxVVRURkNKYXpLaktoUHVZZVVNSENxTnRlNndVdUdTWFRJUHlwUVFRWTZHZUxkMUV6OWtkVmQzSHhOVG9fZlFBM3BfMXVaSGtCU1lKckF0T3RrWTB3UQ?oc=5","date":"2021-06-25","type":"deal","source":"GlobeNewswire","summary":"Roth Capital Partners to Host a Virtual Healthcare Private Company Forum on June 28, 2021 - GlobeNewswire","headline":"Roth Capital Partners to Host a Virtual Healthcare Private Company Forum on June 28, 2021","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}